No, Evolut had a DVI of 0.61, we had 0.62.
its interesting to note Evolut has superior metrics to Sapien, yet Sapien has greater market share.
Ann: 30-day Haemodynamic Results from the DurAVR US EFS Trial, page-40
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.95 |
Change
0.200(1.01%) |
Mkt cap ! $383.4M | |||
| Open | High | Low | Value | Volume |
| $19.95 | $20.00 | $19.83 | $183.2K | 9.187K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 25 | $19.75 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.95 | 472 | 1 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
| AVR (ASX) Chart |